[1]
|
B. A. Rybicki and M. C. Iannuzzi, “Epidemiology of Sarcoidosis: Recent Advances and Future Prospects,” Seminars in Respiratory and Critical Care Medicine, Vol. 28, No. 1, 2007, pp. 22-35. doi:10.1055/s-2007-970331
|
[2]
|
R. K. Allen, R. E. Sellars and P. A. Sandstrom, “A Prospective Study of 32 Patients with Neurosarcoidosis,” Sarcoidosis, Vasculitis and Diffuse Lung Diseases, Vol. 20, No. 2, 2003, pp. 118-125.
|
[3]
|
V. Terushkin, B. J. Stern, M. A. Judson, M. Hagiwara, B. Pramanik, M. Sanchez, et al., “Neurosarcoidosis: Presentations and Management,” Neurologist, Vol. 16, No. 1, 2010, pp. 2-15. doi:10.1097/NRL.0b013e3181c92a72
|
[4]
|
A. V. Patel, D. E. Stickler and W. R. Tyor, “Neurosarcoidosis,” Current Treatment Options in Neurology, Vol. 9, No. 3, 2007, pp. 161-168. doi:10.1007/BF02938405
|
[5]
|
L. Ayala, D. B. Barber, M. R. Lomba and A. C. Able, “Intramedullary Sarcoidosis Presenting as Incomplete Paraplegia: Case Report and Literature Review,” Journal of Spinal Cord Medicine, Vol. 23, No. 2, 2000, pp. 96-99.
|
[6]
|
D. A. Nowak and D. C. Widenka, “Neurosarcoidosis: A Review of Its Intracranial Manifestation,” Journal of Neurology, Vol. 248, No. 5, 2001, pp. 363-372.
doi:10.1007/s004150170175
|
[7]
|
E. E. Lower and K. L. Weiss, “Neurosarcoidosis,” Clinics in Chest Medicine, Vol. 29, No. 3, 2008, pp. 475-492.
doi:10.1016/j.ccm.2008.03.016
|
[8]
|
I. B. Colvin, “Audiovestibular Manifestations of Sarcoidosis: A Review of the Literature,” Laryngoscope, Vol. 116, No. 1, 2006, pp. 75-82.
doi:10.1097/01.mlg.0000184580.52723.9f
|
[9]
|
R. W. Byard, N. Manton and M. Tsokos, “Sarcoidosis and Mechanisms of Unexpected Death,” Journal of Forensic Sciences, Vol. 53, No. 2, 2008, pp. 460-464.
doi:10.1111/j.1556-4029.2008.00662.x
|
[10]
|
S. Saleh, C. Saw, K. Marzouk and O. Sharma, “Sarcoidosis of the Spinal Cord: Literature Review and Report of Eight Cases,” Journal of the National Medical Association, Vol. 98, No. 6, 2006, pp. 965-976.
|
[11]
|
K. Oe, M. Doita, H. Miyamoto, F. Kanda, M. Kurosaka and M. Sumi, “Is Extensive Cervical Laminoplasty an Effective Treatment for Spinal Cord Sarcoidosis Combined with Cervical Spondylosis?” European Spine Journal, Vol. 18, No. 4, 2009, pp. 570-576.
doi:10.1007/s00586-009-0891-2
|
[12]
|
G. Galassi, M. Gibertoni, A Mancini, R. Nemni, G. Volpi, E. Merelli and G. Vacca, “Sarcoidosis of the Peripheral nerve: Clinical, Electrophysiological and Histological Study of Two Cases,” European Neurology, Vol. 23, No. 6, 1984, pp. 459-465. doi:10.1159/000115728
|
[13]
|
T. F. Scott, K. Yandora, A. Valeri, C. Chieffe and C. Schramke, “Aggressive Therapy for Neurosarcoidosis: Long-Term Follow-Up of 48 Treated Patients,” Archives of Neurology, Vol. 64, No. 5, 2007, pp. 691-696.
doi:10.1001/archneur.64.5.691
|
[14]
|
J. P. Zajicek, N. J. Scolding, O. Foster, M. Rovaris, J. Evanson, I. F. Moseley, J. W. Scadding, E. J. Thompson, V. Chamoun, D. H. Miller, W. I. McDonald and D. Mitchell, “Central Nervous System Sarcoidosis: Diagnosis and Management,” Quarterly Journal of Medicine, Vol. 92, No. 2, 1999, pp. 103-117.
doi:10.1093/qjmed/92.2.103
|
[15]
|
H. Akhondi, S. Barochia, B. Holmstrom and M. J. Williams, “Hydrocephalus as a Presenting Manifestation of neurosarcoidosis,” Southern Medical Journal, Vol. 96, No. 4, 2003, pp. 403-406.
doi:10.1097/01.SMJ.0000056648.43258.C0
|
[16]
|
L. R Robinson, R. Brownsberger and G. Raghu, “Respiratory Failure and Hypoventilation Secondary to Neurosarcoidosis,” American Journal of Respiratory and Critical Care Medicine, Vol. 157, No. 4, 1998, pp. 13161318.
|
[17]
|
S. L. Yong, P. Marik, M. Esposito and P. Coulthard, “Supplemental Perioperative Steroids for Surgical Patients with Adrenal Insufficiency,” Cochrane Database of Systematic Reviews, 2009, Article ID: CD005367.
|
[18]
|
F. Fery, L. Plat, P. van de Borne, E. Cogan and J. Mockel, “Impaired Counterregulation of Glucose in a Patient with Hypothalamic Sarcoidosis,” New England Journal of Medicine, Vol. 340, No. 11, 1999, pp. 852-856.
doi:10.1056/NEJM199903183401105
|
[19]
|
M. Jefferson, “Sarcoidosis of the Nervous System,” Brain, Vol. 80, No. 4, 1957, pp. 540-556.
doi:10.1093/brain/80.4.540
|
[20]
|
A. Richard, F. Girard, D. C. Girard, D. Boudreault, P. Chouinard, R. Moumdjian, B A. outhilier, M. Ruel, J. Couture and F. Varin, “Cisatracurium-Induced Neuromuscular Blockade Is Affected by Chronic Phenytoin or Carbamazepine Treatment in Neurosurgical Patients,” Anesthesia & Analgesia, Vol. 100, No. 2, 2005, pp. 538544. doi:10.1213/01.ANE.0000143333.84988.50
|
[21]
|
M. M. Jamal, A. M. Cilursu and E. L. Hoffman, “Sarcoidosis Presenting as Acute Myositis. Report and Review of the Literature,” Journal of Rheumatology, Vol. 15, No. 12, 1988, pp. 1868-1871.
|